Drugs News and Research

RSS

Using artificial intelligence to adjust chemotherapy dosages

Finding the right dose of medication by trial and error can be a painful experience for patients who are already suffering because of their disease. Artificial intelligence can greatly accelerate this process thanks to a new algorithm created by Adrien Coulet, lecturer at the Université de Lorraine and researcher in a joint Inria and Loria team, in collaboration with researchers from Stanford University.

4 Feb 2019

Groundbreaking preventive approach promises to revolutionize treatment of rheumatoid arthritis

The EU- and industry-funded RTCURE project’s groundbreaking approach promises to revolutionise treatment of rheumatoid arthritis, which afflicts millions of people across Europe with joint pain, inflammation and bone and cartilage loss.

4 Feb 2019

Rutgers study uncovers new threat in the opiate epidemic

A Rutgers study has uncovered a new threat in the opiate epidemic: Overdoses of loperamide, an over-the-counter diarrhea medication, have been steadily increasing in number and severity nationwide over five years.

4 Feb 2019

The T2B Infrastructure Center for Respiratory Disease set to enter into the final phase

The Korea Institute of Toxicology (KIT·Chief Dr. Song, Chang-woo) National Center for Efficacy Evaluation of Respiratory Disease Product (NCER·Chief Dr. Lee, Kyu-hong) obtained on January 10 the final decision from the Ministry of Health and Welfare that the T2B Infrastructure Center for Respiratory Disease would enter into the final phase (second phase) with funding of 3 billion KRW over two years.

4 Feb 2019

FDA warns that some home-use test strips may provide inaccurate results

The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.

4 Feb 2019

Children born after fertility treatment do not have greater risk of developing cancer

Children born after assisted reproductive technology do not appear to be at greater risk of developing cancer than other children, according to the first study to look at the long-term cancer risk in ART children compared to those in the general population or who were naturally conceived by subfertile women.

4 Feb 2019

Insect-borne microbes outperform soil bacteria in stopping certain dangerous antibiotic-resistant pathogens

Medicine was transformed in the 20th century by the discovery and development of antibiotics, the vast majority of which came from one source: soil bacteria.

4 Feb 2019

New research uncovers crucial link between polyamines and MYCN

The MYCN oncogene has long been known to be a key cause of a number of deadly solid tumor cancers, including neuroblastoma, which claims more lives of children under the age of 5 than any other cancer.

4 Feb 2019

Newly launched CINECA enables researchers to access clinical research data

Registered researchers will have rapid access to an "unprecedented scale" of clinical research data through the new Common Infrastructure for National Cohorts in Europe, Canada and Africa, launched today.

4 Feb 2019

Lawsuit details how the Sackler family allegedly built an Oxycontin fortune

The first nine months of 2013 started off as a banner year for the Sackler family, owners of the pharmaceutical company that produces OxyContin, the addictive opioid pain medication. Purdue Pharma paid the family $400 million from its profits during that time, claims a lawsuit filed by the Massachusetts attorney general.

4 Feb 2019

Opioid overdose epidemic likely to increase in the U.S in coming years

A study from investigators at the Massachusetts General Hospital Institute for Technology Assessment projects that the opioid overdose epidemic in the U.S. is likely to increase in coming years, and that measures based on restricting access to prescription opioids will have a minimal impact in reducing overdose deaths.

3 Feb 2019

A new approach towards future treatment of diabetes

It is said that the eyes are the window to the soul, but they may also open the door for discovering new ways to achieve immune tolerance to transplanted islets in type 1 diabetes, according to research from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine.

3 Feb 2019

Winners and losers under bold Trump plan to slash drug rebate deals

Few consumers have heard of the secret, business-to-business payments that the Trump administration wants to ban in an attempt to control drug costs.

1 Feb 2019

Newron announces successful completion of patient enrollment in STARS study

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced the successful completion of patient enrollment in its STARS clinical study.

1 Feb 2019

Discovery of proteins that control mucin secretion reveals clues to treating colon, airway diseases

Cells produce mucins at a constant rate, and when exposed to an allergen or pathogen, they produce more mucin in a rapid burst. Both the constant and rapid mucin secretion is controlled by calcium.

1 Feb 2019

Cancer nanomedicine may accelerate metastasis, NUS study finds

Nanoparticles can be found in processed food (e.g. food additives), consumer products (e.g. sunscreen) and even in medicine. While these tiny particles could have large untapped potential and novel new applications, they may have unintended and harmful side effects, according to a recent study by researchers from the National University of Singapore.

1 Feb 2019